Atıf Formatları
The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. Cetin Et Al. , "The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors," TUMOR BIOLOGY , vol.36, no.11, pp.8471-8478, 2015

Cetin, B. Et Al. 2015. The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors. TUMOR BIOLOGY , vol.36, no.11 , 8471-8478.

Cetin, B., Gonu, I. I., Buyukberber, S., Afsar, B., Gumusay, Ö., Algm, E., ... Turan, N.(2015). The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors. TUMOR BIOLOGY , vol.36, no.11, 8471-8478.

Cetin, Bulent Et Al. "The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors," TUMOR BIOLOGY , vol.36, no.11, 8471-8478, 2015

Cetin, Bulent Et Al. "The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors." TUMOR BIOLOGY , vol.36, no.11, pp.8471-8478, 2015

Cetin, B. Et Al. (2015) . "The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors." TUMOR BIOLOGY , vol.36, no.11, pp.8471-8478.

@article{article, author={Bulent Cetin Et Al. }, title={The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors}, journal={TUMOR BIOLOGY}, year=2015, pages={8471-8478} }